<p>The US Food and Drug Administration is planning to allow Americans to get a different booster shot of a Covid-19 vaccine than the one initially taken, the New York Times reported on Monday.</p>.<p>The FDA in September authorised a booster dose of Pfizer Inc and partner BioNTech's two-shot Covid-19 vaccine for those aged 65 and older and some high-risk Americans.</p>.<p>The regulator's advisory panel has also backed the use of Moderna Inc and Johnson & Johnson's Covid-19 vaccine booster shots.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/international/world-news-politics/fda-panel-votes-to-authorise-jj-covid-vaccine-booster-1041031.html">FDA panel votes to authorise J&J Covid vaccine booster</a></strong></p>.<p>The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report <a href="https://nyti.ms/3vmBRYE">said</a>, citing people familiar with the agency's plans.</p>.<p>The FDA declined to comment on the matter.</p>.<p>US health officials have been under pressure to authorize the additional shots after the White House announced plans in August for a widespread booster campaign pending approvals from the FDA and the US Centers for Disease Control and Prevention.</p>.<p>A study by the National Institutes of Health last week showed people who got Johnson & Johnson's Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer and Moderna.</p>.<p><strong>Watch the latest DH Videos here:</strong></p>
<p>The US Food and Drug Administration is planning to allow Americans to get a different booster shot of a Covid-19 vaccine than the one initially taken, the New York Times reported on Monday.</p>.<p>The FDA in September authorised a booster dose of Pfizer Inc and partner BioNTech's two-shot Covid-19 vaccine for those aged 65 and older and some high-risk Americans.</p>.<p>The regulator's advisory panel has also backed the use of Moderna Inc and Johnson & Johnson's Covid-19 vaccine booster shots.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/international/world-news-politics/fda-panel-votes-to-authorise-jj-covid-vaccine-booster-1041031.html">FDA panel votes to authorise J&J Covid vaccine booster</a></strong></p>.<p>The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report <a href="https://nyti.ms/3vmBRYE">said</a>, citing people familiar with the agency's plans.</p>.<p>The FDA declined to comment on the matter.</p>.<p>US health officials have been under pressure to authorize the additional shots after the White House announced plans in August for a widespread booster campaign pending approvals from the FDA and the US Centers for Disease Control and Prevention.</p>.<p>A study by the National Institutes of Health last week showed people who got Johnson & Johnson's Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer and Moderna.</p>.<p><strong>Watch the latest DH Videos here:</strong></p>